GreenPeptide Co., Ltd. reported consolidated and non-consolidated earnings results for the year ended March 31, 2017. For the year, on consolidated basis, the company reported net sales of JPY 529 million. Operating loss was JPY 1,113 million. Ordinary loss was JPY 1,116 million. Loss attributable to owners of parent was JPY 1,113 million or loss of JPY 32.74 per share. Cash outflows from operating activities were JPY 1,067 million. Loss before income taxes was JPY 1,116,928,000. Purchase of property, plant and equipment was JPY 97,237,000. Purchase of intangible assets was JPY 6,605,000. Negative return on shareholders' equity was 28.2%.

For the year, on non-consolidated basis, the company reported net sales of JPY 529 million, operating loss of JPY 1,094 million, ordinary loss of JPY 1,089 million, loss attributable to owners of parent of JPY 1,113 million or loss of JPY 32.74 per share compared to net sales of JPY 822 million, operating loss of JPY 988 million, ordinary loss of JPY 992 million, loss attributable to owners of parent of JPY 994 million or loss of JPY 35.28 per share a year ago.

For the year ending March 31, 2018, the company expects net sales of JPY 280 million, operating loss of JPY 2,000 million, ordinary loss of JPY 2,000 million and net loss of JPY 2,000 million or loss attributable to owners of parents of JPY 53.74 per share.